Skip to main content

Advertisement

Log in

Image-guided intervention in the coagulopathic patient

  • Invited article
  • Published:
Abdominal Radiology Aims and scope Submit manuscript

Abstract

Determining practice parameters for interventional procedures is challenging due to many factors including unreliable laboratory tests to measure bleeding risk, variable usage of standardized terminology for adverse events, poorly defined standards for administration of blood products, and the growing numbers of anticoagulant and antiplatelet medications. We aim to address these and other issues faced by radiologists performing invasive procedures through a review of available literature, and experiential guidance from three academic medical centers. We discuss the significant limitations with respect to using prothrombin-time and international normalized ratio to measure bleeding risk, especially in patients with synthetic defects due to liver function. Factors affecting platelet function including the impact of uremia; recent advances in laboratory testing, including platelet function testing; and thromboelastography are also discussed. A review of the existing literature of fresh-frozen plasma replacement therapy is included. The literature regarding comorbidities affecting coagulation including malignancy, liver failure, and uremia are also reviewed. Finally, the authors present a set of recommendations for laboratory thresholds, corrective transfusions, as well as withholding and restarting medications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Atwell TD, Spanbauer JC, McMenomy BP, et al. (2015) The timing and presentation of major hemorrhage after 18,947 image-guided percutaneous biopsies. Am J Roentgenol 205:190–195. doi:10.2214/AJR.14.13002

    Article  Google Scholar 

  2. Ault MJ, Rosen BT, Scher J, et al. (2015) Thoracentesis outcomes: a 12-year experience. Thorax 70:127–132. doi:10.1136/thoraxjnl-2014-206114

    Article  PubMed  Google Scholar 

  3. Corapi KM, Chen JLT, Balk EM, Gordon CE (2012) Bleeding complications of native kidney biopsy: a systematic review and meta-analysis. Am J Kidney Dis 60:62–73. doi:10.1053/j.ajkd.2012.02.330

    Article  PubMed  Google Scholar 

  4. Atwell TD, Smith RL, Hesley GK, et al. (2010) Incidence of bleeding after 15,181 percutaneous biopsies and the role of aspirin. Am J Roentgenol 194:784–789. doi:10.2214/AJR.08.2122

    Article  Google Scholar 

  5. Caldwell S, Northup PG (2010) Bleeding complication with liver biopsy: is it predictable? Clin Gastroenterol Hepatol 8:826–829. doi:10.1016/j.cgh.2010.06.010

    Article  PubMed  Google Scholar 

  6. McVay PA, Toy PTCY (1991) Lack of increased bleeding after paracentesis and thoracentesis in patients with mild coagulation abnormalities. Transfusion 31:164–171. doi:10.1046/j.1537-2995.1991.31291142949.x

    Article  CAS  PubMed  Google Scholar 

  7. McVay PA, Toy PT (1990) Lack of increased bleeding after liver biopsy in patients with mild hemostatic abnormalities. Am J Clin Pathol 94:747–753

    Article  CAS  PubMed  Google Scholar 

  8. O’Connor SD, Taylor AJ, Williams EC, Winter TC (2009) Coagulation concepts update. Am J Roentgenol 193:1656–1664. doi:10.2214/AJR.08.2191

    Article  Google Scholar 

  9. Patel IJ, Davidson JC, Nikolic B, et al. (2012) Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions. J Vasc Interv Radiol 23:727–736. doi:10.1016/j.jvir.2012.02.012

    Article  PubMed  Google Scholar 

  10. Rockey DC, Caldwell SH, Goodman ZD, et al. (2009) Liver biopsy. Hepatology 49:1017–1044. doi:10.1002/hep.22742

    Article  PubMed  Google Scholar 

  11. National Cancer Institute (2009) Common terminology criteria for adverse events (CTCAE). http://evs.nci.nih.gov/ftp1/CTCAE/About.html. Accessed 12 Jan 2016

  12. Quick AJ (1961) Clinical interpretation of the one-stage prothrombin time. Circulation 24:1422–1428

    Article  CAS  PubMed  Google Scholar 

  13. Burns ER, Goldberg SN, Wenz B (1993) Paradoxic effect of multiple mild coagulation factor deficiencies on the prothrombin time and activated partial thromboplastin time. Am J Clin Pathol 100:94–98

    Article  CAS  PubMed  Google Scholar 

  14. Northup PG, Caldwell SH (2013) Coagulation in liver disease: a guide for the clinician. Clin Gastroenterol Hepatol 11:1064–1074. doi:10.1016/j.cgh.2013.02.026

    Article  PubMed  Google Scholar 

  15. McGill DB, Rakela J, Zinsmeister AR, Ott BJ (1990) A 21-year experience with major hemorrhage after percutaneous liver biopsy. Gastroenterology 99:1396–1400

    CAS  PubMed  Google Scholar 

  16. Seeff LB, Everson GT, Morgan TR, et al. (2010) Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C Trial. Clin Gastroenterol Hepatol 8:877–883. doi:10.1016/j.cgh.2010.03.025

    Article  PubMed  PubMed Central  Google Scholar 

  17. Short SS, Papillon S, Hunter CJ, et al. (2013) Percutaneous liver biopsy: pathologic diagnosis and complications in children. J Pediatr Gastroenterol Nutr 57:644–648. doi:10.1097/MPG.0b013e3182a0e0d8

    Article  PubMed  Google Scholar 

  18. Terjung B, Lemnitzer I, Dumoulin FL, et al. (2003) Bleeding complications after percutaneous liver biopsy. An analysis of risk factors. Digestion 67:138–145. doi:10.1159/000071293

    Article  PubMed  Google Scholar 

  19. Westheim BH, Østensen AB, Aagenæs I, et al. (2012) Evaluation of risk factors for bleeding after liver biopsy in children. J Pediatr Gastroenterol Nutr 55:82–87. doi:10.1097/MPG.0b013e318249c12a

    Article  PubMed  Google Scholar 

  20. Mueller M, Kratzer W, Oeztuerk S, et al. (2012) Percutaneous ultrasonographically guided liver punctures: an analysis of 1961 patients over a period of ten years. BMC Gastroenterol 12:173. doi:10.1186/1471-230X-12-173

    Article  PubMed  PubMed Central  Google Scholar 

  21. Caturelli E, Squillante MM, Andriulli A, et al. (1993) Fine-needle liver biopsy in patients with severely impaired coagulation. Liver 13:270–273

    Article  CAS  PubMed  Google Scholar 

  22. Sandrasegaran K, Thayalan N, Thavanesan R, et al. (2016) Risk factors for bleeding after liver biopsy. Abdom Radiol. doi:10.1007/s00261-016-0655-5

    Google Scholar 

  23. Hollestelle MJ, Geertzen HGM, Straatsburg IH, et al. (2003) Factor VIII expression in liver disease. Thromb Haemost. doi:10.1160/TH03-05-0310

    Google Scholar 

  24. Harmsze AM, van Werkum JW, Hackeng CM, et al. (2012) The influence of CYP2C19*2 and *17 on on-treatment platelet reactivity and bleeding events in patients undergoing elective coronary stenting. Pharmacogenet Genomics 22:169–175. doi:10.1097/FPC.0b013e32834ff6e3

    Article  CAS  PubMed  Google Scholar 

  25. Levi M, Hunt BJ (2015) A critical appraisal of point-of-care coagulation testing in critically ill patients. J Thromb Haemost 13:1960–1967. doi:10.1111/jth.13126

    Article  CAS  PubMed  Google Scholar 

  26. Abdelfattah K, Cripps MW (2015) Thromboelastography and rotational thromboelastometry use in trauma. Int J Surg. doi:10.1016/j.ijsu.2015.09.036

    PubMed  Google Scholar 

  27. Kang YG, Martin DJ, Marquez J, et al. (1985) Intraoperative changes in blood coagulation and thrombelastographic monitoring in liver transplantation. Anesth Analg 64:888–896

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Lacey JV, Penner JA (1977) Management of idiopathic thrombocytopenic purpura in the adult. Semin Thromb Hemost 3:160–174

    CAS  PubMed  Google Scholar 

  29. Kaufman RM, Djulbegovic B, Gernsheimer T, et al. (2015) Platelet transfusion: a Clinical Practice Guideline From the AABBPlatelet transfusion: a clinical practice guideline from the AABB. Ann Intern Med 162:205–213. doi:10.7326/M14-1589

    Article  PubMed  Google Scholar 

  30. Kumar A, Mhaskar R, Grossman BJ, et al. (2015) Platelet transfusion: a systematic review of the clinical evidence. Transfusion 55:1116–1127. doi:10.1111/trf.12943

    Article  PubMed  Google Scholar 

  31. Spector I, Corn M, Ticktin HE (1966) Effect of plasma transfusions on the prothrombin time and clotting factors in liver disease. N Engl J Med 275:1032–1037. doi:10.1056/NEJM196611102751902

    Article  CAS  PubMed  Google Scholar 

  32. Youssef WI, Salazar F, Dasarathy S, et al. (2003) Role of fresh frozen plasma infusion in correction of coagulopathy of chronic liver disease: a dual phase study. Am J Gastroenterol 98:1391–1394. doi:10.1016/S0002-9270(03)00241-7

    Article  PubMed  Google Scholar 

  33. Abdel-Wahab OI, Healy B, Dzik WH (2006) Effect of fresh-frozen plasma transfusion on prothrombin time and bleeding in patients with mild coagulation abnormalities. Transfusion 46:1279–1285. doi:10.1111/j.1537-2995.2006.00891.x

    Article  PubMed  Google Scholar 

  34. Stanworth SJ, Walsh TS, Prescott RJ, et al. (2011) A national study of plasma use in critical care: clinical indications, dose and effect on prothrombin time. Crit Care 15:R108. doi:10.1186/cc10129

    Article  PubMed  PubMed Central  Google Scholar 

  35. Holland LL, Brooks JP (2006) Toward rational fresh frozen plasma transfusion the effect of plasma transfusion on coagulation test results. Am J Clin Pathol 126:133–139. doi:10.1309/NQXHUG7HND78LFFK

    Article  PubMed  Google Scholar 

  36. Sohal AS, Gangji AS, Crowther MA, Treleaven D (2006) Uremic bleeding: pathophysiology and clinical risk factors. Thromb Res 118:417–422. doi:10.1016/j.thromres.2005.03.032

    Article  CAS  PubMed  Google Scholar 

  37. Linthorst GE, Avis HJ, Levi M (2010) Uremic thrombocytopathy is not about urea. JASN 21:753–755. doi:10.1681/ASN.2009111181

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Lee HK, Kim YJ, Jeong JU, et al. (2010) Desmopressin improves platelet dysfunction measured by in vitro closure time in uremic patients. Nephron Clin Pract 114:c248–c252. doi:10.1159/000276576

    Article  CAS  PubMed  Google Scholar 

  39. Manno C, Bonifati C, Torres DD, et al. (2011) Desmopressin acetate in percutaneous ultrasound-guided kidney biopsy: a randomized controlled trial. Am J Kidney Dis 57:850–855. doi:10.1053/j.ajkd.2010.12.019

    Article  CAS  PubMed  Google Scholar 

  40. Lisman T, Porte RJ (2010) Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences. Blood 116:878–885. doi:10.1182/blood-2010-02-261891

    Article  CAS  PubMed  Google Scholar 

  41. Aggarwal A, Puri K, Liangpunsakul S (2014) Deep vein thrombosis and pulmonary embolism in cirrhotic patients: systematic review. World J Gastroenterol 20:5737–5745. doi:10.3748/wjg.v20.i19.5737

    Article  PubMed  PubMed Central  Google Scholar 

  42. Jaffe TA, Raiff D, Ho LM, Kim CY (2015) Management of anticoagulant and antiplatelet medications in adults undergoing percutaneous interventions. AJR Am J Roentgenol 205:421–428. doi:10.2214/AJR.14.13342

    Article  PubMed  Google Scholar 

  43. Llinas RH (2006) Could discontinuation of aspirin therapy be a trigger for stroke? Nat Clin Pract Neurol 2:300–301. doi:10.1038/ncpneuro0196

    Article  PubMed  Google Scholar 

  44. Rodríguez LAG, Cea-Soriano L, Martín-Merino E, Johansson S (2011) Discontinuation of low dose aspirin and risk of myocardial infarction: case-control study in UK primary care. BMJ 343:d4094

    Article  PubMed  Google Scholar 

  45. van Werkum JW, Heestermans AA, Zomer AC, et al. (2009) Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry. J Am Coll Cardiol 53:1399–1409. doi:10.1016/j.jacc.2008.12.055

    Article  PubMed  Google Scholar 

  46. Mehran R, Baber U, Steg PG, et al. (2013) Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study. Lancet 382:1714–1722. doi:10.1016/S0140-6736(13)61720-1

    Article  PubMed  Google Scholar 

  47. Benahmed A, Kianda M, Ghisdal L, et al. (2014) Ticlopidine and clopidogrel, sometimes combined with aspirin, only minimally increase the surgical risk in renal transplantation: a case–control study. Nephrol Dial Transplant 29:463–466. doi:10.1093/ndt/gft385

    Article  CAS  PubMed  Google Scholar 

  48. Trindade AJ, Hirten R, Slattery E, et al. (2015) Endoscopic ultrasound-guided fine-needle aspiration of solid lesions on clopidogrel may not be a high-risk procedure for bleeding: a case series. Dig Endosc . doi:10.1111/den.12565

    Google Scholar 

  49. Abu-Yousef MM, Larson JH, Kuehn DM, et al. (2011) Safety of ultrasound-guided fine needle aspiration biopsy of neck lesions in patients taking antithrombotic/anticoagulant medications. Ultrasound Q 27:157–159. doi:10.1097/RUQ.0b013e31822b5681

    Article  PubMed  Google Scholar 

  50. Melotti MK, Berg WA (2000) Core needle breast biopsy in patients undergoing anticoagulation therapy. Am J Roentgenol 174:245–249. doi:10.2214/ajr.174.1.1740245

    Article  CAS  Google Scholar 

  51. Somerville P, Seifert PJ, Destounis SV, et al. (2008) Anticoagulation and bleeding risk after core needle biopsy. Am J Roentgenol 191:1194–1197. doi:10.2214/AJR.07.3537

    Article  Google Scholar 

  52. Raheem OA, Casey RG, Galvin DJ, et al. (2012) Discontinuation of anticoagulant or antiplatelet therapy for transrectal ultrasound-guided prostate biopsies: a single-center experience. Korean J Urol 53:234–239. doi:10.4111/kju.2012.53.4.234

    Article  PubMed  PubMed Central  Google Scholar 

  53. Whitson MJ, Dikman AE, von Althann C, et al. (2011) Is gastroduodenal biopsy safe in patients receiving aspirin and clopidogrel? a prospective, randomized study involving 630 biopsies. J Clin Gastroenterol 45:228–233. doi:10.1097/MCG.0b013e3181eb5efd

    Article  PubMed  Google Scholar 

  54. Ortel TL (2012) Perioperative management of patients on chronic antithrombotic therapy. Blood 120:4699–4705. doi:10.1182/blood-2012-05-423228

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Douketis JD, Spyropoulos AC, Spencer FA, et al. (2012) Perioperative management of antithrombotic therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141:e326S–e350S. doi:10.1378/chest.11-2298

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Ellis G, John Camm A, Datta SN (2015) Novel anticoagulants and antiplatelet agents; a guide for the urologist. BJU Int 116:687–696. doi:10.1111/bju.13131

    Article  PubMed  Google Scholar 

  57. Oprea AD, Popescu WM (2013) Perioperative management of antiplatelet therapy. Br J Anaesth 111:i3–i17. doi:10.1093/bja/aet402

    Article  PubMed  Google Scholar 

  58. Thomas M, Shen KR (2015) Coagulopathy and anticoagulation during thoracic surgery. Thorac Surg Clin 25:309–323. doi:10.1016/j.thorsurg.2015.04.005

    Article  PubMed  Google Scholar 

  59. van Veen JJ, Makris M (2015) Management of peri-operative anti-thrombotic therapy. Anaesthesia 70:58-e23. doi:10.1111/anae.12900

    Google Scholar 

  60. Williams LA III, Hunter JM Jr, Marques MB, Vetter TR (2014) Periprocedural management of patients on anticoagulants. Clin Lab Med 34:595–611. doi:10.1016/j.cll.2014.06.010

    Article  PubMed  Google Scholar 

  61. Schafer AI (1999) Effects of nonsteroidal anti-inflammatory therapy on platelets. Am J Med 106:25S–36S

    Article  CAS  PubMed  Google Scholar 

  62. Schafer AI (1995) Effects of nonsteroidal antiinflammatory drugs on platelet function and systemic hemostasis. J Clin Pharmacol 35:209–219. doi:10.1002/j.1552-4604.1995.tb04050.x

    Article  CAS  PubMed  Google Scholar 

  63. Lewis SR, Nicholson A, Cardwell ME, et al. (2013) Nonsteroidal anti-inflammatory drugs and perioperative bleeding in paediatric tonsillectomy. Cochrane Database of Syst Rev 7:CD003591

    Google Scholar 

  64. Riggin L, Ramakrishna J, Sommer DD, Koren G (2013) A 2013 updated systematic review & meta-analysis of 36 randomized controlled trials; no apparent effects of non steroidal anti-inflammatory agents on the risk of bleeding after tonsillectomy. Clin Otolaryngol 38:115–129. doi:10.1111/coa.12106

    Article  CAS  PubMed  Google Scholar 

  65. Meek IL, Vonkeman HE, Kasemier J, et al. (2012) Interference of NSAIDs with the thrombocyte inhibitory effect of aspirin: a placebo-controlled, ex vivo, serial placebo-controlled serial crossover study. Eur J Clin Pharmacol 69:365–371. doi:10.1007/s00228-012-1370-y

    Article  PubMed  Google Scholar 

  66. Sarwar A, Boland G, Monks A, Kruskal JB (2015) Metrics for radiologists in the era of value-based health care delivery. RadioGraphics 35:866–876. doi:10.1148/rg.2015140221

    Article  PubMed  Google Scholar 

  67. American College of Radiology (2015) CT Accreditation Program Requirements.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marc Kohli.

Ethics declarations

Conflict of Interest

All authors declare that they have no conflict of interest.

Ethical Approval

This article does not contain any studies with human participants performed by any of the authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kohli, M., Mayo-Smith, W., Zagoria, R. et al. Image-guided intervention in the coagulopathic patient. Abdom Radiol 41, 667–676 (2016). https://doi.org/10.1007/s00261-016-0663-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-016-0663-5

Keywords

Navigation